A 4-year-old, previously healthy girl presented with large, tense bullae involving up to 40% of her body surface area. Her parents described a 12-day history of itchy, papulovesicular lesions that had progressed into large blisters. Your dx?
A 4-year-old, previously healthy girl presented with large, tense bullae involving up to 40% of her body surface area. Her parents described a 12-day history of itchy, papulovesicular lesions that had progressed into large blisters.
Your dx?
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.